HeartSciences (HSCSW) Operating Expenses (2021 - 2026)

HeartSciences (HSCSW) has reported Operating Expenses for 6 consecutive years, with $2.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 31.91% year-over-year to $2.5 million; the trailing twelve-month figure through Apr 2026 stood at $8.4 million (up 0.65% YoY), and the FY2026 full-year result was $8.4 million, up 0.72% from the prior year.
• Operating Expenses climbed to $2.5 million in Q2 2026 per HSCSW's latest filing, from $2.1 million in the prior quarter.
• Across five years, Operating Expenses topped out at $2.5 million in Q2 2026 and bottomed at $1.1 million in Q1 2022.
• Historically, Operating Expenses has averaged $1.8 million across 5 years, with a median of $1.9 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses soared 111.67% in 2022, then slipped 19.29% in 2023.
• Over 5 years, Operating Expenses stood at $1.8 million in 2022, then declined by 11.41% to $1.6 million in 2023, then advanced by 26.25% to $2.0 million in 2024, then climbed by 4.52% to $2.1 million in 2025, then increased by 22.25% to $2.5 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $2.5 million, $2.1 million, and $1.9 million for Q2 2026, Q4 2025, and Q3 2025 respectively.